CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-28
DOI
10.1038/s41467-021-23331-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19
- (2020) Peter Braendstrup et al. CYTOTHERAPY
- Lessons from the A2A Adenosine Receptor Antagonist–Enabled Tumor Regression and Survival in Patients with Treatment-Refractory Renal Cell Cancer
- (2020) Michail V. Sitkovsky Cancer Discovery
- Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells
- (2020) Elham Masoumi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo Studies
- (2020) Simone Nüssing et al. JOURNAL OF IMMUNOLOGY
- Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
- (2020) Junyun Lai et al. NATURE IMMUNOLOGY
- Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
- (2020) You Lu et al. NATURE MEDICINE
- Pharmacological targeting of immune checkpoint A2aR improves function of anti-CD19 CAR T cells in vitro
- (2020) Keyvan Fallah-Mehrjardi et al. IMMUNOLOGY LETTERS
- IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors
- (2020) Lauren Giuffrida et al. MOLECULAR THERAPY
- Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
- (2020) Lukas F. Mager et al. SCIENCE
- Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy
- (2020) Stephen M. Hatfield et al. JOURNAL OF CLINICAL INVESTIGATION
- Antagonism of IAPs enhances CAR T cell efficacy
- (2019) Jessica Michie et al. Cancer Immunology Research
- A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system
- (2019) Martin W. LaFleur et al. Nature Communications
- Supercharging adoptive T cell therapy to overcome solid tumor–induced immunosuppression
- (2019) Sherly Mardiana et al. Science Translational Medicine
- Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
- (2019) Selena Vigano et al. Frontiers in Immunology
- PTPN 2 phosphatase deletion in T cells promotes anti‐tumour immunity and CAR T‐cell efficacy in solid tumours
- (2019) Florian Wiede et al. EMBO JOURNAL
- Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers
- (2018) Tao Jiang et al. BMC CANCER
- Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models
- (2018) Robert D. Leone et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A2AAdenosine Receptor Gene Deletion or Synthetic A2AAntagonist Liberate Tumor-Reactive CD8+T Cells from Tumor-Induced Immunosuppression
- (2018) Jorgen Kjaergaard et al. JOURNAL OF IMMUNOLOGY
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5′-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients
- (2018) Timo J. Vogt et al. OncoImmunology
- A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
- (2018) Stephen B. Willingham et al. Cancer Immunology Research
- Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
- (2018) Kevin Sek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
- (2018) Priyamvada Jayaprakash et al. JOURNAL OF CLINICAL INVESTIGATION
- Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
- (2018) Judith Feucht et al. NATURE MEDICINE
- Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
- (2017) Paul A. Beavis et al. JOURNAL OF CLINICAL INVESTIGATION
- Ensembl 2018
- (2017) Daniel R Zerbino et al. NUCLEIC ACIDS RESEARCH
- CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
- (2017) Levi J. Rupp et al. Scientific Reports
- Evaluation of RNAi and CRISPR technologies by large-scale gene expression profiling in the Connectivity Map
- (2017) Ian Smith et al. PLOS BIOLOGY
- Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery
- (2016) S C Katz et al. CANCER GENE THERAPY
- Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates With Progression of Human Myeloma
- (2016) Alberto L Horenstein et al. MOLECULAR MEDICINE
- CD73-adenosine reduces immune responses and survival in ovarian cancer patients
- (2016) Pierre-Olivier Gaudreau et al. OncoImmunology
- CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
- (2015) Martin Turcotte et al. CANCER RESEARCH
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- High expression of CD39/ENTPD1 in malignant epithelial cells of human rectal adenocarcinoma
- (2015) Bin Zhang et al. TUMOR BIOLOGY
- Ecto-5′-nucleotidase expression is associated with the progression of renal cell carcinoma
- (2015) YI YU et al. Oncology Letters
- Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses
- (2015) Paul A. Beavis et al. Cancer Immunology Research
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
- (2015) Robert D. Leone et al. Computational and Structural Biotechnology Journal
- Contribution of CD39 to the immunosuppressive microenvironment of acute myeloid leukaemia at diagnosis
- (2014) Nicolas Dulphy et al. BRITISH JOURNAL OF HAEMATOLOGY
- Adenosine A2A Receptors Intrinsically Regulate CD8+ T Cells in the Tumor Microenvironment
- (2014) C. Cekic et al. CANCER RESEARCH
- Efficacy of CAR T-cell Therapy in Large Tumors Relies upon Stromal Targeting by IFN
- (2014) A. Textor et al. CANCER RESEARCH
- Hostile, Hypoxia-A2-Adenosinergic Tumor Biology as the Next Barrier to Overcome for Tumor Immunologists
- (2014) M. V. Sitkovsky et al. Cancer Immunology Research
- COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites
- (2014) Thomas J Cradick et al. Molecular Therapy-Nucleic Acids
- Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
- (2013) L. B. John et al. CLINICAL CANCER RESEARCH
- Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia
- (2013) David S. Ritchie et al. MOLECULAR THERAPY
- CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
- (2013) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA-SeQC: RNA-seq metrics for quality control and process optimization
- (2012) David S. DeLuca et al. BIOINFORMATICS
- Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
- (2012) Davis J. McCarthy et al. NUCLEIC ACIDS RESEARCH
- CD73: a potent suppressor of antitumor immune responses
- (2012) Paul. A. Beavis et al. TRENDS IN IMMUNOLOGY
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
- Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor
- (2011) Adam T. Waickman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Ablation by Gene-Modified T Cells in the Absence of Autoimmunity
- (2010) L. X. J. Wang et al. CANCER RESEARCH
- CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
- (2010) D. Jin et al. CANCER RESEARCH
- Adenosine A2A Receptor Is Involved in Cell Surface Expression of A2B Receptor
- (2010) Kengo Moriyama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More